By 2034, the market is projected to reach around $2.9 billion, reflecting a robust compound annual growth rate (CAGR) of about 9.2% during the forecast period from 2025 to 2034. Get a ...

Unlike the failed Theranos company that ended up being a scam, BetterWay does not test the blood in shoebox-size equipment.

Health systems must navigate constant change. Consolidation, transformation, staffing shortages, administrative headaches and much more. It’s a lot. Add to this the disparate operational technologies ...